Herpes zoster in the Czech Republic - Epidemiology and Clinical Manifestations

被引:0
作者
Smetana, J. [1 ]
Salavec, M. [2 ]
Bostikova, V [1 ]
Chlibek, R. [1 ]
Bostik, P. [3 ]
Hanovcova, I [1 ]
Vackova, M. [1 ]
Matulkova, P. [1 ]
Splino, M. [1 ]
机构
[1] Fak Vojenskeho Zdravotnictvi UO, Katedra Epidemiol, Hradec Kralove 50001, Czech Republic
[2] Lekarska Fak UK Hradec Kralove, Klin Nemoci Koznich & Pohlavnich, Katedra Dermatovenerol, Hradec Kralove, Czech Republic
[3] Fak Vojenskeho Zdravotnictvi UO, Ctr Pokrocilych, Hradec Kralove 50001, Czech Republic
来源
EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE | 2010年 / 59卷 / 03期
关键词
herpes zoster; incidence; Czech Republic; clinical manifestations; complications; POSTHERPETIC NEURALGIA; ORAL ACYCLOVIR; CUTANEOUS REACTIONS; NATURAL-HISTORY; PAIN RESOLUTION; RISK-FACTORS; VARICELLA; VACCINATION; BURDEN; PREDNISOLONE;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Smetana J., Salavec M., Bostikova V., Chlibek R., Bostik P., Hanovcova I., Vackova M., Matulkova P., Splino M.: Herpes zoster in the Czech Republic - Epidemiology and Clinical Manifestations Herpes zoster (shingles) is a viral infection of the skin that manifests itself as painful, unilateral vesicular rash. The causative agent is varicella-zoster virus (VZV). Primary infection with VZV causes chickenpox, a common childhood infection, and then the virus lies dormant in the sensory neural ganglia, reactivating to cause shingles. The most important complications are neurological disorders (in particular postherpetic neuralgia) and eye disorders. First-line therapy are antiviral agents. A single vaccine has been registered to date. Herpes zoster occurs sporadically in the Czech Republic and its incidence is long-term stable. In 1990-2008 the average annual incidence was 6,306 cases (61.3 cases/100 000 population), with the lowest number of 5,511 cases (53.5/100 000) reported in 1991 and the highest number of 6,894 cases (67.6/100 000) reported in 2002. The incidence rate in females (69.9/100 000) was 1.4 times as high as in males (49.5/100 000). From the age perspective, the elderly are at a considerably higher risk of developing shingles. In 2008, the incidence rate was the highest in the age group 70 years (155.0/100 000). Nevertheless, the beginning of the upward trend is seen in the age group 45-49 years. Herpes zoster does not show any seasonal trend.
引用
收藏
页码:138 / 146
页数:9
相关论文
共 53 条
[1]   Herpes zoster and vaccination: A clinical review [J].
Adams, Erin N. ;
Parnapy, Sarah ;
Bautista, Philip .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (09) :724-727
[2]   VALACICLOVIR COMPARED WITH ACYCLOVIR FOR IMPROVED THERAPY FOR HERPES-ZOSTER IN IMMUNOCOMPETENT ADULTS [J].
BEUTNER, KR ;
FRIEDMAN, DJ ;
FORSZPANIAK, C ;
ANDERSEN, PL ;
WOOD, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1546-1553
[3]  
Cerny Z, 1996, Cas Lek Cesk, V135, P244
[4]   The incidence of shingles and its implications for vaccination policy [J].
Chapman, RS ;
Cross, KW ;
Fleming, DM .
VACCINE, 2003, 21 (19-20) :2541-2547
[5]   Post-herpetic neuralgia in older adults - Evidence-based approaches to clinical management [J].
Christo, Paul J. ;
Hobelmann, Greg ;
Maine, David N. .
DRUGS & AGING, 2007, 24 (01) :1-19
[6]   Varicella zoster virus latency, neurological disease and experimental models: an update [J].
Cohrs, RJ ;
Gilden, DH ;
Mahalingam, R .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 :751-762
[7]   Membrane fusion mediated by herpesvirus glycoproteins: the paradigm of varicella-zoster virus [J].
Cole, NL ;
Grose, C .
REVIEWS IN MEDICAL VIROLOGY, 2003, 13 (04) :207-222
[8]  
CROOKS RJ, 1991, SCAND J INFECT DIS, P62
[9]   THE COMPLETE DNA-SEQUENCE OF VARICELLA-ZOSTER VIRUS [J].
DAVISON, AJ ;
SCOTT, JE .
JOURNAL OF GENERAL VIROLOGY, 1986, 67 :1759-1816
[10]  
Doerr HW, 1996, INFEKTIONSBIOLOGIE E, V1, P1